• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.伴有共济失调的先天性代谢缺陷:当前及未来的治疗选择
Cells. 2023 Sep 19;12(18):2314. doi: 10.3390/cells12182314.
2
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia.一种用于研究新型治疗药物乙酰-L-亮氨酸的主方案,针对三种超罕见神经退行性疾病:尼曼-匹克 C 型、神经节苷脂贮积症和共济失调毛细血管扩张症。
Trials. 2021 Jan 22;22(1):84. doi: 10.1186/s13063-020-05009-3.
3
Movement Disorders in Treatable Inborn Errors of Metabolism.可治疗性先天性代谢缺陷相关的运动障碍。
Mov Disord. 2019 May;34(5):598-613. doi: 10.1002/mds.27568. Epub 2018 Dec 17.
4
Acetyl-leucine slows disease progression in lysosomal storage disorders.乙酰亮氨酸可减缓溶酶体贮积症的疾病进展。
Brain Commun. 2020 Dec 20;3(1):fcaa148. doi: 10.1093/braincomms/fcaa148. eCollection 2021.
5
Treatable Ataxias: How to Find the Needle in the Haystack?可治疗的共济失调:如何在大海捞针?
J Mov Disord. 2022 Sep;15(3):206-226. doi: 10.14802/jmd.22069. Epub 2022 Sep 7.
6
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.乙酰-DL-亮氨酸对小脑共济失调的影响(ALCAT试验):一项多中心、跨国、随机、双盲、安慰剂对照、交叉III期试验的研究方案。
BMC Neurol. 2017 Jan 10;17(1):7. doi: 10.1186/s12883-016-0786-x.
7
[Inborn errors of metabolism in adult neurology].[成人神经病学中的先天性代谢缺陷]
Rev Neurol (Paris). 2013 Feb;169 Suppl 1:S63-9. doi: 10.1016/S0035-3787(13)70062-6.
8
Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease.乙酰-DL-亮氨酸(ADLL)在桑德霍夫病小鼠模型中的有益作用。
J Clin Med. 2020 Apr 8;9(4):1050. doi: 10.3390/jcm9041050.
9
Current and Promising Therapies in Autosomal Recessive Ataxias.常染色体隐性遗传性共济失调的现有及有潜力疗法。
CNS Neurol Disord Drug Targets. 2018;17(3):161-171. doi: 10.2174/1871527317666180419115029.
10
Autosomal recessive cerebellar ataxias.常染色体隐性遗传性小脑共济失调
Orphanet J Rare Dis. 2006 Nov 17;1:47. doi: 10.1186/1750-1172-1-47.

引用本文的文献

1
Bilateral vestibulopathy in Alexander disease type II- a case report.II型亚历山大病中的双侧前庭病——病例报告
Eur Arch Otorhinolaryngol. 2025 May 6. doi: 10.1007/s00405-025-09416-7.

本文引用的文献

1
258th ENMC international workshop Leigh syndrome spectrum: genetic causes, natural history and preparing for clinical trials 25-27 March 2022, Hoofddorp, Amsterdam, The Netherlands.第258届ENMC国际研讨会: Leigh综合征谱系——遗传病因、自然病史及临床试验准备,2022年3月25 - 27日,荷兰阿姆斯特丹霍夫多普
Neuromuscul Disord. 2023 Aug;33(8):700-709. doi: 10.1016/j.nmd.2023.06.002. Epub 2023 Jun 15.
2
Late adult-onset Niemann Pick type C (NPC): An "atypical" typical presentation at the age of 62.成人晚发型尼曼-匹克C型病(NPC):62岁时的“非典型”典型表现。
Parkinsonism Relat Disord. 2024 Mar;120:105460. doi: 10.1016/j.parkreldis.2023.105460. Epub 2023 Jun 9.
3
Current advancements in therapy for Niemann-Pick disease: progress and pitfalls.尼曼-匹克病治疗的当前进展:进展与困境
Expert Opin Pharmacother. 2023 May-Aug;24(11):1229-1247. doi: 10.1080/14656566.2023.2215386. Epub 2023 May 21.
4
KCNA1 gain-of-function epileptic encephalopathy treated with 4-aminopyridine.KCNA1 功能获得性癫痫性脑病用 4-氨基吡啶治疗。
Ann Clin Transl Neurol. 2023 Apr;10(4):656-663. doi: 10.1002/acn3.51742. Epub 2023 Feb 15.
5
Efficacy and safety clinical trial with efavirenz in patients diagnosed with adult Niemann-pick type C with cognitive impairment.依非韦伦治疗成人尼曼-匹克 C 型伴认知障碍患者的疗效和安全性临床试验。
Medicine (Baltimore). 2022 Dec 2;101(48):e31471. doi: 10.1097/MD.0000000000031471.
6
Efficacy and Safety of N-Acetyl-l-Leucine in Children and Adults With GM2 Gangliosidoses.N-乙酰-L-亮氨酸在儿童和成人 GM2 神经节苷脂贮积症中的疗效和安全性。
Neurology. 2023 Mar 7;100(10):e1072-e1083. doi: 10.1212/WNL.0000000000201660. Epub 2022 Dec 1.
7
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension.奥马伐索隆治疗弗里德赖希共济失调的疗效:MOXIe扩展研究的延迟启动分析
Mov Disord. 2023 Feb;38(2):313-320. doi: 10.1002/mds.29286. Epub 2022 Nov 29.
8
Intravenous 2-hydroxypropyl-β-cyclodextrin (Trappsol® Cyclo™) demonstrates biological activity and impacts cholesterol metabolism in the central nervous system and peripheral tissues in adult subjects with Niemann-Pick Disease Type C1: Results of a phase 1 trial.静脉注射2-羟丙基-β-环糊精(Trappsol® Cyclo™)在患有1型尼曼-匹克病的成年受试者的中枢神经系统和外周组织中表现出生物活性并影响胆固醇代谢:1期试验结果。
Mol Genet Metab. 2022 Dec;137(4):309-319. doi: 10.1016/j.ymgme.2022.10.004. Epub 2022 Oct 17.
9
Clinical and genetic study of ataxia with vitamin E deficiency: A case report.维生素E缺乏性共济失调的临床与遗传学研究:一例报告
World J Clin Cases. 2022 Aug 16;10(23):8271-8276. doi: 10.12998/wjcc.v10.i23.8271.
10
Multi-omics in classical galactosemia: Evidence for the involvement of multiple metabolic pathways.经典半乳糖血症的多组学研究:涉及多种代谢途径的证据。
J Inherit Metab Dis. 2022 Nov;45(6):1094-1105. doi: 10.1002/jimd.12548. Epub 2022 Aug 25.

伴有共济失调的先天性代谢缺陷:当前及未来的治疗选择

Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.

作者信息

Bremova-Ertl Tatiana, Hofmann Jan, Stucki Janine, Vossenkaul Anja, Gautschi Matthias

机构信息

Department of Neurology, University Hospital Bern (Inselspital) and University of Bern, 3010 Bern, Switzerland.

Center for Rare Diseases, University Hospital Bern (Inselspital) and University of Bern, 3010 Bern, Switzerland.

出版信息

Cells. 2023 Sep 19;12(18):2314. doi: 10.3390/cells12182314.

DOI:10.3390/cells12182314
PMID:37759536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10527548/
Abstract

A number of hereditary ataxias are caused by inborn errors of metabolism (IEM), most of which are highly heterogeneous in their clinical presentation. Prompt diagnosis is important because disease-specific therapies may be available. In this review, we offer a comprehensive overview of metabolic ataxias summarized by disease, highlighting novel clinical trials and emerging therapies with a particular emphasis on first-in-human gene therapies. We present disease-specific treatments if they exist and review the current evidence for symptomatic treatments of these highly heterogeneous diseases (where cerebellar ataxia is part of their phenotype) that aim to improve the disease burden and enhance quality of life. In general, a multimodal and holistic approach to the treatment of cerebellar ataxia, irrespective of etiology, is necessary to offer the best medical care. Physical therapy and speech and occupational therapy are obligatory. Genetic counseling is essential for making informed decisions about family planning.

摘要

许多遗传性共济失调是由先天性代谢缺陷(IEM)引起的,其中大多数在临床表现上具有高度异质性。及时诊断很重要,因为可能有针对特定疾病的治疗方法。在本综述中,我们按疾病对代谢性共济失调进行了全面概述,重点介绍了新的临床试验和新兴疗法,特别强调了首次人体基因疗法。如果存在针对特定疾病的治疗方法,我们会予以介绍,并回顾目前针对这些高度异质性疾病(小脑共济失调是其表型的一部分)的对症治疗证据,这些治疗旨在减轻疾病负担并提高生活质量。一般来说,无论病因如何,采用多模式和整体方法治疗小脑共济失调对于提供最佳医疗护理是必要的。物理治疗、言语和职业治疗是必不可少的。遗传咨询对于就计划生育做出明智决策至关重要。